Publications by authors named "Thomas Kleen"

Claim this Profile
S
SITC cancer immunotherapy resource document: a compass in the land of biomarker discovery.
Siwen Hu-Lieskovan, Srabani Bhaumik, Kavita Dhodapkar, Jean-Charles J B Grivel, Sumati Gupta, Thomas O Kleen

J Immunother Cancer· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunodynamics: a cancer immunotherapy trials network review of immune monitoring in immuno-oncology clinical trials.
Holbrook E Kohrt, Paul C Tumeh, Don Benson, Nina Bhardwaj, Joshua Brody, Thomas Kleen

J Immunother Cancer· March 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Novel technologies and emerging biomarkers for personalized cancer immunotherapy.
Jianda Yuan, Priti S Hegde, Raphael Clynes, Periklis G Foukas, Alexandre Harari, Thomas O Kleen

J Immunother Cancer· January 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Q
Quantitative real-time PCR assisted cell counting (qPACC) for epigenetic - based immune cell quantification in blood and tissue.
Thomas Oliver Kleen, Jianda Yuan

J Immunother Cancer· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology.
Hideaki Tahara, Marimo Sato, Magdalena Thurin, Ena Wang, Lisa H Butterfield, Thomas O Kleen

J Transl Med· June 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A systematic approach to biomarker discovery; preamble to "the iSBTc-FDA taskforce on immunotherapy biomarkers".
Lisa H Butterfield, Mary L Disis, Bernard A Fox, Peter P Lee, Samir N Khleif, Thomas O Kleen

J Transl Med· December 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dissociated production of perforin, granzyme B, and IFN-gamma by HIV-specific CD8(+) cells in HIV infection.
Stefanie Kuerten, Tobias M Nowacki, Thomas O Kleen, Robert J Asaad, Paul V Lehmann

AIDS Res Hum Retroviruses· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Recipient-specific tolerance after HLA-mismatched umbilical cord blood stem cell transplantation.
Thomas O Kleen, Suzanne Kadereit, Laura R Fanning, Jennifer Jaroscak, Pingfu Fu

Transplantation· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tc1 effector diversity shows dissociated expression of granzyme B and interferon-gamma in HIV infection.
Thomas O Kleen, Robert Asaad, Samuel J Landry, Bernhard O Boehm, Magdalena Tary-Lehmann

AIDS· February 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Deficient IFN-gamma expression in umbilical cord blood (UCB) T cells can be rescued by IFN-gamma-mediated increase in NFATc2 expression.
Suzanne Kadereit, Gwendolyn R Junge, Thomas Kleen, Margaret M Kozik, Beth A Kaminski

J Clin Immunol· November 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis